Serzone Related Published Studies
Well-designed clinical trials related to Serzone (Nefazodone)
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial. [2007.02]
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. [2005.05]
Nefazodone in out-patient treatment of inhaled cocaine dependence: a randomized double-blind placebo-controlled trial. [2005.04]
Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence. [2005.03]
Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study. [2004.10]
A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. [2004.06]
Nefazodone treatment of comorbid alcohol dependence and major depression. [2004.03]
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers. [2004.02]
Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. [2004]
Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone. [2003.11]
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. [2003.10.15]
Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. [2003.10]
Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial. [2003.06]
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. [2003.03.15]
Nefazodone decreases anxiety during marijuana withdrawal in humans. [2003.01]
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. [2003]
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. [2002.08]
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. [2002.06]
Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. [2002.06]
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. [2002.05]
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. [2002.01.15]
Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol. [2002]
A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment. [2001.09]
Opposite effects of nefazodone in two human models of anxiety. [2001.08]
Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. [2001.06]
Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. [2001.05]
Which depressed patients respond to nefazodone and when? [2001.03]
Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation. [2001.03]
Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. [2001.01]
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. [2000.05.18]
Well-designed clinical trials possibly related to Serzone (Nefazodone)
Managing the patient with co-morbid depression and an anxiety disorder. [2008]
Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. [2007.12]
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. [2007.04.18]
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. [2007.02]
Dropouts versus completers among chronically depressed outpatients. [2007.01]
Combination treatment for acute depression is superior only when psychotherapy is added to medication. [2007]
[Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study] [2005.03]
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. [2005.02]
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. [2004.12]
Therapeutic reactance as a predictor of outcome in the treatment of chronic depression. [2003.12]
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. [2003.12]
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. [2003.11.25]
Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. [2003.09.30]
Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication. [2003.05]
Other research related to Serzone (Nefazodone)
A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. [2007.10]
Coadministration of nefazodone and desipramine: a pharmacokinetic interaction study. [2007.05]
Other possibly related research studies
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. [2008.06]
The impact of mental illness on sexual dysfunction. [2008]
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. [2008.04]
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy. [2008.02]
Antidepressant-induced liver injury. [2007.07]
[Applications and safety of modern antidepressants in patients with liver diseases] [2007]
Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. [2007.07]
The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events. [2007.01]
Caffeine metabolism during prolonged treatment of rats with antidepressant drugs. [2007.11]
|
